Clinical Trials Logo

Clinical Trial Summary

SPINERY is a Radiofrequency (RF) device designed for palliative treatment of patients with painful metastatic bone tumors involving vertebral bodies, sacrum, iliac crest and peri-acetabulum. In particular, SPINERY is conceived for pain reduction in patients affected by metastatic bone tumors involving the vertebral bodies, sacrum, iliac crest and periacetabulum, in patients with indication for Standard Therapy and in patients who have failed, not candidates or refuse Standard Therapy. Primary objective of the SPARTA Study is to demonstrate that SPINERY RF device is effective in short-term (3 months) pain reduction in patients affected by metastatic bone tumors and to demonstrate that SPINERY RF device is safe in the RF ablation treatment of metastatic bone tumors, without causing device-related adverse events including, in particular, nerve injury. Primary objective hypothesis will be obtained with Brief Pain Inventory (BPI) scale performance questionnaire in terms of palliative treatment. Change of Worst Pain Score expressed as average reduction of 2 BPI (Brief Pain Inventory) scores will be calculated as: μc = worst-pain 3-month - worst-pain baseline A negative average value for change in pain represents a lowering of the subject's pain score (an improvement, or reduction in pain) and a positive value represents an increase in the subject's pain score (a worsening or increase in pain). Worst pain score at the target treatment site will be collected from the BPI in the past 24 hours.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05467540
Study type Interventional
Source Axon srl
Contact
Status Recruiting
Phase N/A
Start date July 11, 2022
Completion date November 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT00294151 - Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer Phase 3
Recruiting NCT03951493 - Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases Phase 3
Terminated NCT01527292 - Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis N/A
Terminated NCT01654068 - Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine N/A
Completed NCT05985434 - Prospective Observational Study on Vertebral Metastasis